AstraZeneca seeks U.S. approval for new COVID treatment
AstraZeneca seeks U.S. approval for new COVID treatment
October 05, 2021
AstraZeneca has requested emergency use authorization from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.
Post A Comment:
0 comments:
Leave a comment. Thanks!